Alnylam Pharmaceuticals
ALNY
ALNY
372 hedge funds and large institutions have $14B invested in Alnylam Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 123 increasing their positions, 125 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
2% less repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 125
11% less capital invested
Capital invested by funds: $15.8B → $14B (-$1.74B)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
372
Holding in Top 10
6
Calls
$130M
Puts
$120M
Top Buyers
| 1 | +$62.6M | |
| 2 | +$39.2M | |
| 3 | +$31.3M | |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$26.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$23.9M |
Top Sellers
| 1 | -$110M | |
| 2 | -$57.1M | |
| 3 | -$53.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$49M |
| 5 |
SPC
Slate Path Capital
New York
|
-$31M |